MedTrace Logo

Endometrial Cancer Vaginal Fluid Specimen Collection Study

NCT07544680 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4200

Last updated 2026-04-22

No results posted yet for this study

Summary

This is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.

Conditions

  • Abnormal Uterine Bleeding (AUB)
  • Endometrial Cancer
  • Atypical Endometrial Hyperplasia
  • Endometrial Hyperplasia With Atypia
  • Endometrial Intraepithelial Neoplasia

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2028-04-24
Completion
2028-04-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07544680 on ClinicalTrials.gov